Use of Ephedra-containing products and risk for hemorrhagic stroke

Neurology

Volumn 60, Issue 1, 2003, Pages 132-135

  Morgenstern, L B ^a   Viscoli, C M ^a   Kernan, W N ^a   Brass, L M ^a   Broderick, J P ^a   Feldmann, E ^a   Wilterdink, J L ^a   Brott, T ^a   Horwitz, R I ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EPHEDRA EXTRACT;

ADULT; AGE DISTRIBUTION; ALCOHOL CONSUMPTION; ANAMNESIS; ARTICLE; BODY MASS; CIGARETTE SMOKING; CLINICAL FEATURE; CONTROLLED STUDY; DOSE RESPONSE; FAMILY HISTORY; FEMALE; HEMORRHAGIC SHOCK; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

EID: 0037435503     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000042092.20411.5B     Document Type: Article

References (8)

1. Blanck HM, Khan LK, Serdula MK. Use of nonprescription weight loss products: results from a multistate survey. JAMA 2001;286:930-935.
2. Samenuk D, Link MS, Homoud MK, et al. Adverse cardiovascular events temporally associated with Ma Huang, an herbal source of ephedrine. Mayo Clin Proc 2002;77:12-16.
3. Haller CA, Benowitz NL. Adverse cardiovascular and central nervous system events associated with dietary supplements containing Ephedra alkaloids. N Engl J Med 2000;343:1833-1838.
4. Health Canada. Health Canada requests a recall of certain products containing Ephedra/ephedrine. Available at: www.hc-sc.gc.ca. Accessed July 1, 2002.
5. Bruno A, Nolte KB, Chapin J. Stroke associated with ephedrine use. Neurology 1993;43:1313-1316.
6. Haller CA, Jacob P III, Benowitz NL. Pharmacology of Ephedra alkaloids and caffeine after single-dose dietary supplement use. Clin Pharmacol Ther 2002;71:411-413.
7. Kernan WN, Viscoli CM, Brass LM, et al. Phenylpropanolamine and the risk of hemorrhagic stroke. N Engl J Med 2000;343:1826-1832.
8. Wooten MR, Khangure MS, Murphy MJ. Intracerebral hemorrhage and vasculitis related to ephedrine abuse. Ann Neurol 1983;13:337-340.